As of June 30, 2024, Chaoju Eye Science (02219) announced its performance for the six-month period, during which the group achieved revenue...
According to the financial app Zhitong Finance, Chaoju Eye Science (02219) announced its performance for the six-month period ending on June 30, 2024. During this period, the group's revenue increased by 0.734 billion yuan (RMB), a year-on-year increase of 6.01%. The net profit attributable to shareholders decreased by 0.136 billion yuan, a year-on-year decrease of 9.4%. The basic earnings per share were 0.2 yuan.
The announcement stated that the increase in revenue was mainly due to the acquisition of eye hospitals and optometry centers, which increased the group's market share.